Jeff Saunders, PhD
Home
About Us
Structure
Current Events
Past Events
Video Gallery
Policy & Reports
Awards
Media Coverage
Internship/Volunteers
Legal
Contact Us
 
 
Jeff Saunders, PhD
Senior Vice President of Drug Discovery
Casma Therapeutics

Jeff Saunders brings over 25 years of drug discovery, team building and leadership experience in start-up and early stage discovery organizations. Over the last decade he has been a pioneer and leader in developing and evolving outsourcing models for effective and highly productive drug design teams.

Jeff joined Nuvalent Therapeutics in 2017 as vice president of chemistry and was a co-founder of Resilience Therapeutics in 2014, a company developing therapies for anxiety- and trauma-related disorders. Prior to that, he held the position of vice president of small molecule drug discovery at Ember Therapeutics. Before joining Ember in 2012, Jeff was the vice president of chemistry at Agios. He also worked as a consultant at Elixir Pharmaceuticals, where he managed all chemistry and related intellectual property for five years. Prior to this, he held the position of principal investigator at Vertex Pharmaceuticals, where he worked for 14 years as chemistry head and project head for multiple programs. Previously, he was a research scientist at the Squibb Institute for Medical Research.

Jeff received his A.B. in chemistry from Hope College in Michigan, earned his PhD in synthetic organic chemistry at the University of South Carolina and held an NIH postdoctoral fellowship at the University of Pennsylvania.

© 2007 - USA India Chamber of Commerce Home | About us | Policy | Events | Photo Gallery | Awards | Media Coverage | Legal | Contact us